Effects of oxytocin and vasopressin on the neural response to unreciprocated cooperation within brain regions involved in stress and anxiety in men and women

Brain Imaging and Behavior

Volumn 10, Issue 2, 2016, Pages 581-593

  Chen, Xu ^a,b   Hackett, Patrick D ^a   DeMarco, Ashley C ^c   Feng, Chunliang ^a   Stair, Sabrina ^b   Haroon, Ebrahim ^b   Ditzen, Beate ^a,b,d   Pagnoni, Giuseppe ^e   Rilling, James K ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Amygdala; Anterior insula; Anxiety; Functional magnetic resonance imaging (fMRI); Oxytocin; Social cooperation

Indexed keywords

OXYTOCIN; PLACEBO; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

ADULT; AMYGDALA; ANTERIOR INSULA; ANXIETY; ANXIETY DISORDER; ARTICLE; BOLD SIGNAL; BRAIN REGION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE POTENTIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL INTERACTION; STRESS; ADOLESCENT; BRAIN; BRAIN CORTEX; COOPERATION; DRUG THERAPY; HUMAN RELATION; INTRANASAL DRUG ADMINISTRATION; MENTAL STRESS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES; SOCIAL BEHAVIOR; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; AMYGDALA; ANXIETY; BRAIN; CEREBRAL CORTEX; COOPERATIVE BEHAVIOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MAGNETIC RESONANCE IMAGING; MALE; OXYTOCIN; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; VASOPRESSINS; YOUNG ADULT;

EID: 84930341064     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-015-9411-7     Document Type: Article

References (70)

1. Altemus, M., Jacobson, K. R., Debellis, M., Kling, M., Pigott, T., Murphy, D. L., et al. (1999). Normal CSF oxytocin and NPY levels in OCD. Biological Psychiatry, 45(7), 931–933.
2. Anderson, I. M., McKie, S., Elliott, R., Williams, S. R., & Deakin, J. F. (2008). Assessing human 5-HT function in vivo with pharmacoMRI. Neuropharmacology, 55(6), 1029–1037.
3. Axelrod, R. M. (1984). The evolution of cooperation. New York: Basic Books.
4. Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011). Social effects of oxytocin in humans: context and person matter. Trends in Cognitive Sciences, 15(7), 301–309.
5. Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008). Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron, 58(4), 639–650.
6. Bertsch, K., Gamer, M., Schmidt, B., Schmidinger, I., Walther, S., Kastel, T., et al. (2013). Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. The American Journal of Psychiatry, 170(10), 1169–1177.
7. Bielsky, I. F., Hu, S. B., Szegda, K. L., Westphal, H., & Young, L. J. (2004). Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology, 29(3), 483–493.
8. Boccia, M. L., Petrusz, P., Suzuki, K., Marson, L., & Pedersen, C. A. (2013). Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience, 253, 155–164.
9. Churchland, P. S., & Winkielman, P. (2012). Modulating social behavior with oxytocin: how does it work? What does it mean? Hormones and Behavior, 61(3), 392–399.
10. Cosmides, L., & Tooby, J. (2000). The cognitive neuroscience of social reasoning. In M. S. Gazzaniga (Ed.), The new cognitive neurosciences (pp. 1259–1270). Cambridge: The MIT Press.
11. Costa, P. T., Jr., & McCrae, R. R. (1992). Revised NEO personality inventory (NEO-PI-R) professional manual. Odessa: Psychological Assessment Resources, Inc.
12. De Dreu, C. K. (2012). Oxytocin modulates the link between adult attachment and cooperation through reduced betrayal aversion. Psychoneuroendocrinology, 37(7), 871–880.
13. De Goeij, D. C., Dijkstra, H., & Tilders, F. J. (1992). Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology, 131(2), 847–853.
14. Declerck, C. H., Boone, C., & Kiyonari, T. (2014). The effect of oxytocin on cooperation in a prisoner’s dilemma depends on the social context and a person’s social value orientation. Social Cognitive and Affective Neuroscience, 9(6), 802–809.
15. Del-Ben, C. M., Ferreira, C. A., Sanchez, T. A., Alves-Neto, W. C., Guapo, V. G., de Araujo, D. B., et al. (2012). Effects of diazepam on BOLD activation during the processing of aversive faces. Journal of Psychopharmacology, 26(4), 443–451.
16. Dell'osso, B., & Lader, M. (2013). Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European Psychiatry, 28(1), 7–20.
17. Derick, S., Cheng, L. L., Voirol, M. J., Stoev, S., Giacomini, M., Wo, N. C., et al. (2002). [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors. Endocrinology, 143(12), 4655–4664.
18. Ditzen, B., Schaer, M., Gabriel, B., Bodenmann, G., Ehlert, U., & Heinrichs, M. (2009). Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biological Psychiatry, 65(9), 728–731.
19. Domes, G., Heinrichs, M., Glascher, J., Buchel, C., Braus, D. F., & Herpertz, S. C. (2007). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biological Psychiatry, 62(10), 1187–1190.
20. Domes, G., Lischke, A., Berger, C., Grossmann, A., Hauenstein, K., Heinrichs, M., et al. (2010). Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology, 35(1), 83–93.
21. Eisenberger, N. I., Lieberman, M. D., & Williams, K. D. (2003). Does rejection hurt? An FMRI study of social exclusion. Science, 302(5643), 290–292.
22. Engelmann, M., Wotjak, C. T., Ebner, K., & Landgraf, R. (2000). Behavioural impact of intraseptally released vasopressin and oxytocin in rats. Experimental Physiology, 85, 125S–130S.
23. Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. The American Journal of Psychiatry, 164(10), 1476–1488.
24. Falk, A., Fehr, E., & Fischbacher, U. (2008). Testing theories of fairness - intentions matter. Games and Economic Behavior, 62(1), 287–303.
25. Goodson, J. L., & Thompson, R. R. (2010). Nonapeptide mechanisms of social cognition, behavior and species-specific social systems. Current Opinion in Neurobiology, 20(6), 784–794.
26. Greve, D. N., & Fischl, B. (2009). Accurate and robust brain image alignment using boundary-based registration. NeuroImage, 48(1), 63–72.
27. Guastella, A. J., Howard, A. L., Dadds, M. R., Mitchell, P., & Carson, D. S. (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology, 34(6), 917–923.
28. Hall, S. S., Lightbody, A. A., McCarthy, B. E., Parker, K. J., & Reiss, A. L. (2012). Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology, 37(4), 509–518.
29. Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54(12), 1389–1398.
30. Heinrichs, M., von Dawans, B., & Domes, G. (2009). Oxytocin, vasopressin, and human social behavior. Frontiers in Neuroendocrinology, 30(4), 548–557.
31. Huber, D., Veinante, P., & Stoop, R. (2005). Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science, 308(5719), 245–248.
32. Hurlemann, R., Patin, A., Onur, O. A., Cohen, M. X., Baumgartner, T., Metzler, S., et al. (2010). Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. Journal of Neuroscience, 30(14), 4999–5007.
33. Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002). Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage, 17(2), 825–841.
34. King-Casas, B., Sharp, C., Lomax-Bream, L., Lohrenz, T., Fonagy, P., & Montague, P. R. (2008). The rupture and repair of cooperation in borderline personality disorder. Science, 321(5890), 806–810.
35. Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., et al. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25(49), 11489–11493.
36. Koen, N., & Stein, D. J. (2011). Pharmacotherapy of anxiety disorders: a critical review. Dialogues in Clinical Neuroscience, 13(4), 423–437.
37. Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435(7042), 673–676.
38. Kubzansky, L. D., Mendes, W. B., Appleton, A. A., Block, J., & Adler, G. K. (2012). A heartfelt response: oxytocin effects on response to social stress in men and women. Biological Psychology, 90(1), 1–9.
39. Labuschagne, I., Phan, K. L., Wood, A., Angstadt, M., Chua, P., Heinrichs, M., et al. (2010). Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology, 35(12), 2403–2413.
40. Lakey, B., Tardiff, T. A., & Drew, J. B. (1994). Negative social interactions - assessment and relations to social support, cognition, and psychological distress. Journal of Social and Clinical Psychology, 13(1), 42–62.
41. Lee, R. J., Coccaro, E. F., Cremers, H., McCarron, R., Lu, S. F., Brownstein, M. J., et al. (2013). A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study. Frontiers in Systems Neuroscience, 7, 100.
42. Liebsch, G., Wotjak, C. T., Landgraf, R., & Engelmann, M. (1996). Septal vasopressin modulates anxiety-related behaviour in rats. Neuroscience Letters, 217(2–3), 101–104.
43. Loup, F., Tribollet, E., Dubois-Dauphin, M., & Dreifuss, J. J. (1991). Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Research, 555(2), 220–232.
44. Macdonald, K., & Feifel, D. (2014). Oxytocins role in anxiety: A critical appraisal. Brain Res.
45. MacDonald, K., MacDonald, T. M., Brune, M., Lamb, K., Wilson, M. P., Golshan, S., et al. (2013). Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression. Psychoneuroendocrinology, 38(12), 2831–2843.
46. Mak, P., Broussard, C., Vacy, K., & Broadbear, J. H. (2012). Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. Journal of Psychopharmacology, 26(4), 532–542.
47. McClure, E. B., Parrish, J. M., Nelson, E. E., Easter, J., Thorne, J. F., Rilling, J. K., et al. (2007). Responses to conflict and cooperation in adolescents with anxiety and mood disorders. Journal of Abnormal Child Psychology, 35(4), 567–577.
48. Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011). Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nature Reviews Neuroscience, 12(9), 524–538.
49. Neumann, I. D. (2008). Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. Journal of Neuroendocrinology, 20(6), 858–865.
50. Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013). Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology, 38(10), 1985–1993.
51. Paulus, M. P., Feinstein, J. S., Castillo, G., Simmons, A. N., & Stein, M. B. (2005). Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Archives of General Psychiatry, 62(3), 282–288.
52. Pitman, R. K., Orr, S. P., & Lasko, N. B. (1993). Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder. Psychiatry Research, 48(2), 107–117.
53. Rilling, J. K., Glenn, A. L., Jairam, M. R., Pagnoni, G., Goldsmith, D. R., Elfenbein, H. A., et al. (2007). Neural correlates of social cooperation and non-cooperation as a function of psychopathy. Biological Psychiatry, 61(11), 1260–1271.
54. Rilling, J. K., Goldsmith, D. R., Glenn, A. L., Jairam, M. R., Elfenbein, H. A., Dagenais, J. E., et al. (2008). The neural correlates of the affective response to unreciprocated cooperation. Neuropsychologia, 46(5), 1256–1266.
55. Rilling, J. K., DeMarco, A. C., Hackett, P. D., Thompson, R., Ditzen, B., Patel, R., et al. (2012). Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men. Psychoneuroendocrinology, 37(4), 447–461.
56. Rilling, J. K., Demarco, A. C., Hackett, P. D., Chen, X., Gautam, P., Stair, S., et al. (2014). Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction. Psychoneuroendocrinology, 39, 237–248.
57. Sanfey, A. G., Rilling, J. K., Aronson, J. A., Nystrom, L. E., & Cohen, J. D. (2003). The neural basis of economic decision-making in the ultimatum game. Science, 300(5626), 1755–1758.
58. Smith, S. M. (2002). Fast robust automated brain extraction. Human Brain Mapping, 17(3), 143–155.
59. Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wullner, U., Maier, W., et al. (2013). Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Scientific Reports, 3, 3440.
60. Surget, A., & Belzung, C. (2008). Involvement of vasopressin in affective disorders. European Journal of Pharmacology, 583(2–3), 340–349.
61. Thompson, R. R., George, K., Walton, J. C., Orr, S. P., & Benson, J. (2006). Sex-specific influences of vasopressin on human social communication. Proceedings of the National Academy of Sciences of the United States of America, 103(20), 7889–7894.
62. Trivers, R. L. (1971). The evolution of reciprocal altruism. The Quarterly Review of Biology, 46(1), 35–57.
63. Uzefovsky, F., Shalev, I., Israel, S., Knafo, A., & Ebstein, R. P. (2012). Vasopressin selectively impairs emotion recognition in men. Psychoneuroendocrinology, 37(4), 576–580.
64. Veenema, A. H., Bredewold, R., & De Vries, G. J. (2013). Sex-specific modulation of juvenile social play by vasopressin. Psychoneuroendocrinology, 38(11), 2554–2561.
65. Viviani, D., Charlet, A., van den Burg, E., Robinet, C., Hurni, N., Abatis, M., et al. (2011). Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science, 333(6038), 104–107.
66. Weisman, O., Zagoory-Sharon, O., Schneiderman, I., Gordon, I., & Feldman, R. (2013). Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety. Psychoneuroendocrinology, 38(5), 694–701.
67. Wigton, R., Radua, J., Allen, P., Averbeck, B., Meyer-Lindenberg, A., McGuire, P., et al. (2015). Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. Journal of Psychiatry and Neuroscience, 40(1), E1–22.
68. Woo, C. W., Krishnan, A., & Wager, T. D. (2014). Cluster-extent based thresholding in fMRI analyses: pitfalls and recommendations. NeuroImage, 91, 412–419.
69. Zelena, D., Domokos, A., Barna, I., Mergl, Z., Haller, J., & Makara, G. B. (2008). Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats. Endocrinology, 149(5), 2576–2583.
70. Zink, C. F., Kempf, L., Hakimi, S., Rainey, C. A., Stein, J. L., & Meyer-Lindenberg, A. (2011). Vasopressin modulates social recognition-related activity in the left temporoparietal junction in humans. Translations Psychiatry, 1, e3.